Skip to main content
Premium Trial:

Request an Annual Quote

ArcherDx Comprehensive Thyroid and Lung Assay

ArcherDx has launched its Archer Comprehensive Thyroid and Lung assay, a next-generation sequencing target enrichment panel.

The assay combines complementary RNA- and DNA-specific NGS library preparation panels to detect gene fusions, point mutations, RNA abundance levels, and copy number variations from FFPE and fine needle aspiration samples.

Turnaround time for the assay, from sample extraction to data reporting, is three to five days.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.